Atlas Trials

Response to Immunotherapy in MMR-deficient Localized Colon Cancer

Clinical trial NCT05662527 · COMPLETED

Trial details

NCT number
NCT05662527
Sponsor
Camilla Qvortrup
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colon Cancer
Start date
2023-02-22
Primary completion
2024-06-06
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.